Press Releases

Date	Title	Company
08-Dec-2025	Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies	Businesswire
08-Dec-2025	Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz	ACCESS Newswire
07-Dec-2025	MSP Recovery, Inc. Announces Conclusion of SEC Investigation: No Intention to Recommend Enforcement Action Against the Company, its CEO, John H. Ruiz, or its Officers	ACCESS Newswire
07-Dec-2025	Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma	Businesswire
07-Dec-2025	BioInvent Presents Promising Early Phase 2a BI-1808 Monotherapy Data in CTCL at ASH 2025	ACCESS Newswire
07-Dec-2025	Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science	ACCESS Newswire
07-Dec-2025	Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering	ACCESS Newswire
07-Dec-2025	Star Therapeutics Presents Interim Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease, Demonstrating Substantial Bleed Reductions in All Patients, at ASH Annual Meeting	Businesswire
06-Dec-2025	Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma	Businesswire
06-Dec-2025	Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera	Businesswire
06-Dec-2025	Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)	Businesswire
06-Dec-2025	Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting	Businesswire
06-Dec-2025	Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting	Businesswire
06-Dec-2025	Genetix Participates in the American Society of Hematology’s (ASH) Exclusive Press Program & Shares Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation	Businesswire
06-Dec-2025	Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions	Businesswire
06-Dec-2025	AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio	ACCESS Newswire
06-Dec-2025	Ayrmid Reports Promising New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease	ACCESS Newswire
06-Dec-2025	Shinoda Dental Named Official Distributor of VHF Milling Machines, Strengthening Its Position in Digital Dentistry	ACCESS Newswire
05-Dec-2025	Mice Model Market Trends and Growth Opportunities by Segment & Region 2025-2032 - Transformative Innovations in Genetic Engineering Propel Mice Model Research in Oncology and Rare Diseases - ResearchAndMarkets.com	Businesswire
05-Dec-2025	Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome	Businesswire